Literature DB >> 7783731

Update: management of patients with suspected viral hemorrhagic fever--United States.

.   

Abstract

In 1988, CDC published guidelines for managing patients with suspected viral hemorrhagic fever (VHF) (1). Pending a comprehensive review of the 1988 guidelines, this notice provides interim recommendations that update the 1988 guidelines for healthcare settings in the United States. This update applies to four viruses that cause syndromes of VHF: Lassa, Marburg, Ebola, and Congo-Crimean hemorrhagic fever viruses; although the risk and/or mode of nosocomial transmission differs for each of these viruses, the limited data do not permit clear distinctions.

Entities:  

Mesh:

Year:  1995        PMID: 7783731

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  21 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.

Authors:  P Onguru; S Dagdas; H Bodur; M Yilmaz; E Akinci; S Eren; G Ozet
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia.

Authors:  Timothy J Whitman; Philip E Coyne; Alan J Magill; David L Blazes; Michael D Green; Wilbur K Milhous; Timothy H Burgess; Daniel Freilich; Sybil A Tasker; Ramzy G Azar; Timothy P Endy; Christopher D Clagett; Gregory A Deye; G Dennis Shanks; Gregory J Martin
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

4.  Crimean-Congo hemorrhagic fever: Risk factors and control measures for the infection abatement.

Authors:  Saadia Aslam; Muhammad Shahzad Latif; Muhammad Daud; Zia Ur Rahman; Bushra Tabassum; Muhammad Sohail Riaz; Anwar Khan; Muhammad Tariq; Tayyab Husnain
Journal:  Biomed Rep       Date:  2015-11-18

5.  Evaluation of patients with Crimean-Congo hemorrhagic fever in Bolu, Turkey.

Authors:  A Duran; A Küçükbayrak; T Ocak; N I Hakyemez; T Taþ; M Karadađ; Z F Mengelođlu
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

Review 6.  Heat illness in athletes: the dangerous combination of heat, humidity and exercise.

Authors:  Eric E Coris; Arnold M Ramirez; Daniel J Van Durme
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

7.  Ebola Virus Inactivation by Detergents Is Annulled in Serum.

Authors:  Jeroen J A van Kampen; Andrei Tintu; Henk Russcher; Pieter L A Fraaij; Chantal B E M Reusken; Mikel Rijken; Jaap J van Hellemond; Perry J J van Genderen; Rob Koelewijn; Menno D de Jong; Elaine Haddock; Robert J Fischer; Vincent J Munster; Marion P G Koopmans
Journal:  J Infect Dis       Date:  2017-10-17       Impact factor: 5.226

8.  Safe IV opioid titration in patients with severe acute pain.

Authors:  Chris Pasero
Journal:  J Perianesth Nurs       Date:  2010-10       Impact factor: 1.084

9.  Preparing a community hospital to manage work-related exposures to infectious agents in BioSafety level 3 and 4 laboratories.

Authors:  George F Risi; Marshall E Bloom; Nancy P Hoe; Thomas Arminio; Paul Carlson; Tamara Powers; Heinz Feldmann; Deborah Wilson
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

10.  Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit.

Authors:  Mark G Kortepeter; James W Martin; Janice M Rusnak; Theodore J Cieslak; Kelly L Warfield; Edwin L Anderson; Manmohan V Ranadive
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.